Thrombosis in otherwise well children with the factor V Leiden mutation

J Pediatr. 1996 Mar;128(3):324-8. doi: 10.1016/s0022-3476(96)70275-5.

Abstract

Objective: To determine whether resistance to activated protein C caused by the factor V Leiden mutation (Arg506 to Gln) is associated with thrombosis occurring during childhood.

Study design: Children with thrombosis were screened for activated protein C resistance. Children found resistant to activated protein C had DNA analysis for the factor V Leiden mutation. Family members of the children with activated protein C resistance were similarly studied.

Results: Three of fourteen children examined had abnormal normalized activated protein C sensitivity ratios. One child had protein S deficiency. The children had hyperlipidemia. Molecular confirmation of the factor V Leiden mutation was obtained for all three children. Family members of each of the three children were affected.

Conclusions: Children have thromboses in association with the factor V Leiden mutation, as do adults. This mutation may be identified as an isolated risk factor or in association with other risk factors for thrombosis.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Blood Coagulation Tests
  • Case-Control Studies
  • Child
  • Factor V / genetics*
  • Female
  • Humans
  • Male
  • Mutation
  • Pedigree
  • Protein C / metabolism
  • Risk Factors
  • Thrombosis / blood
  • Thrombosis / epidemiology
  • Thrombosis / genetics*

Substances

  • Protein C
  • factor V Leiden
  • Factor V